Status:
UNKNOWN
Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Berlin Institute of Health
Conditions:
Glomerulonephritis Acute
Eligibility:
All Genders
18+ years
Brief Summary
Urinary T lymphocytes may be predictive for clinical outcome in patients with ANCA associated glomerulonephritis (ANCA GN). The investigators hypothesize that the amount of CD4+ effector/memory T cell...
Eligibility Criteria
Inclusion
- Informed consent
- Biopsy proven ANCA related glomerulonephritis
- In absence of biopsy clinical diagnosis of ANCA related glomerulonephritis
Exclusion
- Biopsy proven non-ANCA related kidney disease
- Active menstrual bleeding
- Urinary tract infection
- Kidney transplantation during observational period
Key Trial Info
Start Date :
November 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT04320667
Start Date
November 19 2019
End Date
December 1 2022
Last Update
July 29 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Deutschland, Germany, 10117
2
The Royal Free London
London, United Kingdom, NW3 2QG